Welcome to the e-CCO Library!

P295 VALIDation of the IBD-Disk instrument for assessing disability in inflammatory bowel diseases in a population-based cohort: The VALIDate study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Le Berre1, A. Bourreille1, M. Flamant1, G. Bouguen2, L. Siproudhis2, M. Dewitte2, N. Dib3, E. Cesbron-Metivier3, T. Goronflot4, P.A. Gourraud4, E. Kerdreux5, A. Poinas6, C. Trang-Poisson1

Created: Thursday, 30 January 2020, 10:12 AM
P295: Absence of mucosal healing in patients undergoing assessment of mucosal healing with a normal PUCAI score in pediatric ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sarbagili-Shabat C.*1, Wardi J.2, Boaz M.3, Levine A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P295: Comparative Assessment of Infliximab Trough Levels between Point-of-Care Testing and current Standard of Care (enzyme linked immunosorbent assay) in patients with Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Maniero, D.(1);Lorenzon, G.(1);Marsilio, I.(1);Rigo, A.(1);Cardin, R.(1);Facchin, S.(1);Barberio, B.(1);D'Incà, R.(1);Zingone, F.(1);Bahur, B.(2);Bray, K.R.(3);Savarino, E.V.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P295: Correlation between sonographic measurements in inflammatory bowel diseases and biological markers of disease activity
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Les*, C. Gheorghe

Created: Thursday, 21 February 2019, 9:14 AM
P295: Hocus Pocus: The Role Of Hand-Held Ultrasonography In Predicting Disease Extension And Endoscopic Activity In Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Rispo, A.(1)*;Calabrese, G.(1);Testa, A.(1);Patturelli, M.(1);Imperatore, N.(2);Nardone, O.M.(1);Guarino, A.D.(1);Cantisani, N.M.(1);Toro, B.(1);Castiglione, F.(1);
Created: Friday, 14 July 2023, 11:05 AM
P295: Impact of superimposed cytomegalovirus infection on the outcomes of ulcerative colitis flare-up
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

H. J. Kim*1, S. J. Oh1, Y-W. Kim2, J. R. Moon1, H-S. Kim3, C. K. Lee1

Created: Friday, 22 February 2019, 9:41 AM
P295: Proctitis during Crohn's disease, would it be a factor in the sustainability of anoperineal fistulas ?
Year: 2022
Source: ECCO'22
Authors: Mtir, M.(1);Hassine, H.(1);Kahlaoui, F.(1);Cherif, D.(1);Tlili, R.(1);Kchir, H.(1);Maamouri, N.(1);
Created: Friday, 11 February 2022, 3:52 PM
P295: The Ulcerative Colitis Endoscopic Index of Severity is useful to predict medium- to long-term prognosis in ulcerative colitis patients with clinical remission
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Arai*1, M. Naganuma1, S. Sugimoto1, H. Kiyohara1, K. Ohno1, M. Mutaguchi1, K. Mori1, K. Nanki1, S. Mizuno1, R. Bessho1, Y. Nakazato2, N. Inoue3, H. Ogata2, Y. Iwao2, T. Kanai1

Created: Friday, 22 February 2019, 9:49 AM
P296 Quality of reporting of lesions detected at surveillance colonoscopy for IBD
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. SHARMA1, A. Virk2, O. Nardone3, S. Smith3, P. Rimmer4, U. Shivaji3, S. Ghosh5, M. Iacucci5

Created: Thursday, 30 January 2020, 10:12 AM
P296: Effect of upadacitinib on patient-reported symptoms by the new Ulcerative Colitis Symptoms Questionnaire (UC-SQ) in patients with moderate to severe ulcerative colitis: data from the Phase 2b study U-ACHIEVE
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Ghosh*1, F. Aberra2, R. Cross3, W. Zhou4, N. Chen4, W-J. Lee4, R. Panaccione5

Created: Friday, 22 February 2019, 9:41 AM
P296: Evaluation of the new liaison faecal calprotectin assay
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

N. Hammoudi1, H. Manceau2, C. Stefanescu1, D. Debuyser2, Y. Bouhnik1, 3, H. Puy2, 3, K. Peoc’h*2, 3

Created: Friday, 22 February 2019, 9:49 AM
P296: Levels of engagement in physical activity and fatigue in IBD patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Gatt1*, J. Schembri1, K.H. Katsanos2, D.K. Christodoulou2, D. Balomenos2, K. Karmiris3, C. Pontas4, U. Kopylov5, I. Koutroubakis6, K. Foteinogiannopoulou6, A. Fábián7, T. Molnár7, D. Zammit1, P. Ellul1, G.J. Mantzaris4

Created: Thursday, 21 February 2019, 9:14 AM
P296: MAGNIFI-CD index is appropriate for treatment monitoring in perianal Crohn's Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Beek, K.(1);Mulders, L.(2)*;Tielbeek, J.(1);Horsthuis, K.(1);Buskens, C.(3);D'Haens, G.(2);Gecse, K.(2);Stoker, J.(1);
Created: Friday, 14 July 2023, 11:05 AM
P296: Persistent symptoms, CRP elevation and treatment changes over time in Crohn's disease patients are associated with bowel damage progression as expressed by deterioration of Lemann Index score
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zezos P.*1, Chawla T.P.2, Weizman A.V.1, Nguyen G.C.1, Narula N.1, Kabakchiev B.3, Milgrom R.3, Croitoru K.1, Steinhart A.H.1, Silverberg M.S.1

Created: Wednesday, 20 February 2019, 10:36 AM
P296: Stopping 5-aminosalicylic acid in patients with ulcerative colitis who are in clinical remission does not increase risks of flare
Year: 2021
Source: ECCO'21 Virtual
Authors: Mak, J.W.Y.(1);Yuen, N.T.K.(1);Yip, T.C.F.(1);Lam, R.H.M.(1);Lam, B.K.H.(1);Chan, F.K.L.(1);Ng , S.C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P297 Novel serum soluble markers of histological healing in ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

O.M. Nardone1, L. Jeffery1, A. Bazarova2, A. Acharjee3, G. Gkoutos3, D. Zardo4, U.N. Shivaji1, S.C. Smith1, S. Ghosh1, M. Iacucci1

Created: Thursday, 30 January 2020, 10:12 AM
P297: Evaluation of the clinical course of Adolescent inflammatory bowel disease patients at Nottingham University Hospital
Year: 2018
Source: ECCO '18 Vienna
Authors:

D.-c. Osei-Bordom*, A.A. Thi, E. Williams, N. Yusoff, N. Ahmad, T. Horne, F. Abbasi, Y. Mildrid, D. Devadason, E. Simon, T. Card, G. Moran

Created: Thursday, 21 February 2019, 9:14 AM
P297: Fecal calprotectin accurately predicts symptomatic relapse in children and adolescents with inflammatory bowel disease in clinical remission
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Diederen K.*1, Hoekman D.1, Leek A.2, Wolters V.2, Benninga M.1, Hummel T.3, de Meij T.4, Koot B.1, Tabbers M.1, Benninga M.1, Kindermann A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P297: HLA-DQA1*05 allele and its association with the secondary loss of response to infliximab in patients with Inflammatory Bowel Disease.
Year: 2021
Source: ECCO'21 Virtual
Authors: Angulo McGrath, I.(1);Bracho González, M.(1);Ocaña Ledesma, A.(1);Olmedo Martín, R.V.(1);
Created: Wednesday, 2 June 2021, 4:12 PM